Focus: Prolific Machines is a public biotechnology company specializing in a photomolecular platform designed to manufacture difficult-to-produce proteins. The company operates from Emeryville, CA and represents a niche technology platform play rather than a traditional pipeline-driven biotech.
Profile data last refreshed 16h ago · AI intelligence enriched 2w ago
Prolific Machines is a high-risk, high-conviction bet on platform technology rather than a derisked biotech career move; suitable only for technologists or entrepreneurial professionals comfortable with execution risk and absent near-term validation.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Prolific Machines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Prolific Machines's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo